Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$592M |
| 2 |
Advanced Micro Devices
AMD
|
+$510M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$427M |
| 4 |
Paychex
PAYX
|
+$383M |
| 5 |
MetLife
MET
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.18B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$576M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$564M |
| 4 |
Apple
AAPL
|
+$555M |
| 5 |
JPMorgan Chase
JPM
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.21% |
| 2 | Healthcare | 13.42% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Mirum Pharmaceuticals
MIRM
$6.02B
| $515K | ﹤0.01% |
23,368
-826
| -3% | -$16.9K |
|
|
PLL
3627
DELISTED
Piedmont Lithium
PLL
| $515K | ﹤0.01% |
7,061
-46
| -0.6% | -$2.58K |
|
3628
Nomura Holdings
NMR
$29B
| $514K | ﹤0.01% |
121,948
+24,741
| +25% | +$112K |
|
3629
Citizens Community Bancorp
CZWI
$200M
| $513K | ﹤0.01% |
33,996
+657
| +2% | +$9.88K |
|
3630
Pliant Therapeutics
PLRX
$66.3M
| $513K | ﹤0.01% |
73,299
-163
| -0.2% | -$1.66K |
|
3631
Schwab US Broad Market ETF
SCHB
$45.2B
| $513K | ﹤0.01% |
28,839
+357
| +1% | +$6.27K |
|
3632
WBI BullBear Value 3000 ETF
WBIF
$23.8M
| $512K | ﹤0.01% |
16,114
-800
| -5% | -$24.9K |
|
|
AKYA
3633
DELISTED
Akoya BioSciences
AKYA
| $511K | ﹤0.01% |
46,543
+9,027
| +24% | +$105K |
|
3634
Dimensional US Core Equity 2 ETF
DFAC
$49.9B
| $511K | ﹤0.01% |
18,511
-270
| -1% | -$7.39K |
|
|
UBFO
3635
DELISTED
United Security Bancshares
UBFO
| $511K | ﹤0.01% |
61,528
+719
| +1% | +$5.96K |
|
3636
Cytosorbents Corp
CTSO
$22.8M
| $510K | ﹤0.01% |
159,690
| – | – |
|
3637
InnovAge Holding
INNV
$1.42B
| $510K | ﹤0.01% |
79,384
-1,188,376
| -94% | -$6M |
|
3638
Taysha Gene Therapies
TSHA
$1.92B
| $510K | ﹤0.01% |
78,237
+2,067
| +3% | +$15.5K |
|
3639
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$771M
| $509K | ﹤0.01% |
8,991
+3,817
| +74% | +$220K |
|
3640
Forum Energy Technologies
FET
$932M
| $507K | ﹤0.01% |
22,173
+4,480
| +25% | +$91.5K |
|
3641
CEL-SCI Corp
CVM
$26M
| $506K | ﹤0.01% |
4,297
+55
| +1% | +$8.95K |
|
|
NAGE
3642
Niagen Bioscience
NAGE
$241M
| $505K | ﹤0.01% |
205,406
-60
| -0% | -$164 |
|
|
EAR
3643
DELISTED
Eargo, Inc. Common Stock
EAR
| $505K | ﹤0.01% |
4,765
+713
| +18% | +$70.4K |
|
|
EXTN
3644
DELISTED
Exterran Corporation
EXTN
| $505K | ﹤0.01% |
81,392
-642
| -0.8% | -$3.42K |
|
3645
Alpha Teknova
TKNO
$396M
| $504K | ﹤0.01% |
36,464
-4,911
| -12% | -$77.3K |
|
|
ASXC
3646
DELISTED
Asensus Surgical, Inc.
ASXC
| $504K | ﹤0.01% |
804,141
-13,552
| -2% | -$10.4K |
|
3647
Unity Bancorp
UNTY
$619M
| $499K | ﹤0.01% |
17,841
-802
| -4% | -$22.9K |
|
|
CANO
3648
DELISTED
Cano Health, Inc.
CANO
| $497K | ﹤0.01% |
782
+125
| +19% | +$78.8K |
|
3649
Everspin Technologies
MRAM
$410M
| $496K | ﹤0.01% |
56,919
+16,245
| +40% | +$156K |
|
|
DFUS
3650
Dimensional US Equity ETF
DFUS
$21.8B
| $495K | ﹤0.01% |
10,091
+4,944
| +96% | +$239K |
|
Similar funds
Bank of New York Mellon's Q1 2022 Portfolio in Review
As of Q1 2022, Bank of New York Mellon held 4,798 positions worth $516B, down 6.9% from $554B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q1 2022 filing shows 182 new, 1,981 increased, 2,086 reduced and 146 closed positions. Its largest new stake was Constellation Energy: 6,682,470 shares worth $376M. The largest sale was Oracle, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2022 buy was Constellation Energy: 6,682,470 shares worth $376M.
- Bank of New York Mellon added most to S&P Global in Q1 2022, an estimated $592M increase.
- Bank of New York Mellon's biggest Q1 2022 reduction was Oracle, cutting an estimated $1.18B.
- Bank of New York Mellon fully exited Xilinx Inc in Q1 2022, selling an estimated $576M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $516B portfolio in Q1 2022.
- Bank of New York Mellon opened 182 new positions and closed 146 in Q1 2022.
- Bank of New York Mellon's portfolio value fell 6.9% quarter-over-quarter to $516B.
Based on Bank of New York Mellon's 13F filing for Q1 2022, filed 11 May 2022.